Shareholdings
| Concept |
2021-04-01 to 2022-03-31 |
As at 2022-03-31 |
|---|---|---|
| Shareholdings | ||
| Reporting company | ||
| Investment shares held for purposes other than pure investment | ||
| Shares not listed | ||
| Number of issues | — |
34
xbrli:pure
|
| Carrying amount | — |
4,752,000,000
JPY
|
| Number of issues whose number of shares increased |
7
xbrli:pure
|
— |
| Total acquisition cost for increased shares |
859,000,000
JPY
|
— |
| Reason for increase in number of shares |
・ 一層の取引強化のため
・医薬品事業戦略における関係の維持・強化のため
|
— |
| Number of issues whose number of shares decreased |
2
xbrli:pure
|
— |
| Total sale amount for decreased shares |
90,000,000
JPY
|
— |
| Shares other than those not listed | ||
| Number of issues | — |
10
xbrli:pure
|
| Carrying amount | — |
25,236,000,000
JPY
|
| Number of issues whose number of shares increased |
3
xbrli:pure
|
— |
| Total acquisition cost for increased shares |
759,000,000
JPY
|
— |
| Reason for increase in number of shares |
・ 一層の取引強化のため
・医薬品事業戦略における関係の維持・強化のため
|
— |
| Number of issues whose number of shares decreased |
2
xbrli:pure
|
— |
| Total sale amount for decreased shares |
2,338,000,000
JPY
|
— |